Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands-Reference-Cited by-同舟云学术

Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands

Published:2016-10-04 Issue: Volume: Page:i4924
ISSN:1756-1833
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Dijkstra Maaike G,van Zummeren Marjolein,Rozendaal Lawrence,van Kemenade Folkert J,Helmerhorst Theo J M,Snijders Peter J F,Meijer Chris J L M,Berkhof Johannes

Publisher

BMJ

Subject

General Engineering

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA extended interventional nucleic acid longitudinal study: Clinical performance of Aptima messenger RNA HPV testing in cervical cancer screening with a 9‐year follow‐up;Cancer Cytopathology;2024-08-19

2. Cervical cancer screening efficacy using SurePath, ThinPrep and conventional cytology: A large data set analysis from the Japan Cancer Society;Cytopathology;2024-08-08

3. Immediate risk of cervical intraepithelial neoplasia and diagnostic value of colposcopy among cytology-negative women with oncogenic HPV: a retrospective study;BMC Women's Health;2024-07-24

4. Risk of cervical high-grade squamous intraepithelial neoplasia in cytologic negative and persistently high-risk human papillomavirus positive patients according to genotypes: a retrospective single center analysis;BMC Infectious Diseases;2024-06-04

5. Comparison of HPV-positive triage strategies combining extended genotyping with cytology or p16/ki67 dual staining in the Italian NTCC2 study;eBioMedicine;2024-06